BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Z Lens LLC Receives SBIR Phase I Award From SBIR


4/9/2013 9:28:26 AM

ALBANY, N.Y., April 9, 2013 /PRNewswire/ -- Z Lens LLC announces a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant award to support development of its novel accommodating intraocular lens (IOL). This $150,000 Phase I grant enables Z Lens to measure the forces of accommodation in the eye using a proprietary technique to capture the movement the ciliary body exerts on the zonules.

Current IOLs are unable to capture the normal forces exerted on the capsular bag and do not provide much accommodation because once an IOL is inserted into the capsular bag, the bag collapses and becomes rigid thereby limiting movement. The Z Lens approach is to create a functional bond between zonules and the intraocular lens system bypassing the "elastic" role of the capsular bag and resulting in a completely novel Accommodative-Disaccommodative Intraocular Lens (AD-IOL) System. Our novel design captures those forces by using individual haptic components that adhere to the bag before the bag is cut to free the ZCH to move. The ZCH then mimics the normal accommodative action of the bag. This AD-IOL system is expected to be superior to other premium IOLs on the market and the optimal choice for cataract sufferers.

"We greatly appreciate the support of the NSF in our product development. Our novel approach to capturing accommodative forces has already shown promising results in our animal experiments. Our goal is to develop an AD-IOL that provides true accommodation and glasses-free living to patients after cataract surgery. This NSF grant will enable us to capture the data we need for product development," said Dr. Paul Beer inventor and founder of Z Lens.

Z Lens LLC is a privately funded, emerging technology company that is developing a novel intraocular lens (IOL) that provides significant accommodation to replace a human lens following cataract surgery. The goal is an IOL that can restore adequate vision for glasses-free living. Successful proof of concept testing suggests the Z Lens approach is the next generational step forward from monofocal IOLs currently used for most cataract surgery. The market for a premium IOL that can truly restore accommodation is expected to grow significantly with the aging population.

Related links:

http://www.zlensllc.com

SOURCE Z Lens LLC



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES